E5768
Monoclonal Anti-Eotaxin-2 antibody produced in mouse
clone 61016.11, purified immunoglobulin, lyophilized powder
Synonyme(s) :
Anti-MPIF-2
Se connecter pour consulter les tarifs organisationnels et contractuels.
A propos de cet article
Conjugate:
unconjugated
Clone:
61016.11, monoclonal
Application:
ELISA (c), Neutral, WB
Citations:
8
biological source
mouse
Quality Level
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
61016.11, monoclonal
form
lyophilized powder
species reactivity
human
technique(s)
capture ELISA: suitable, neutralization: suitable, western blot: 1-2 μg/mL
isotype
IgG1
UniProt accession no.
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... CCL24(6369)
General description
Accumulation of eosinophils is the hallmark of several medical conditions such as infections and systemic diseases. A number of chemokines stimulate the proliferation, migration and accumulation of eosinophils at the site of inflammation. Eotaxin-2 is chemoattractant that selectively acts on eosinophils and has minimal effect on other leukocytes. It is secreted in response to TNF-α, IL-5 or IL-3. The effect of Eotaxin is mediated by specific eotaxin receptor that induces activation of Gi proteins, MAPK signaling and involves changes in intracellular calcium levels and cytoskeletal reorganization. Eotaxin receptor is present on eosinophils, basophils and T-helper cells. Eotaxin coordinates the accumulation of these cells in response to allergic inflammation and homing of eosinophils to gastrointestinal tract and mucosal tissues
Monoclonal Anti-Eotaxin-2 (MPIF-2) recognizes recombinant human eotaxin-2, less than 0.03 % cross-reactivity with recombinant human eotaxin, MIP-1α, and MCP-3.
Monoclonal Anti-Eotaxin-2 (MPIF-2) recognizes recombinant human eotaxin-2, less than 0.03 % cross-reactivity with recombinant human eotaxin, MIP-1α, and MCP-3.
Immunogen
recombinant human eotaxin-2.
Application
Anti-eotaxin-2 antibody may be used for neutralization assays at a working concentration of 1-5 μg/ml in the presence of 100 ng/ml of human recombinant eotaxin-2. The antibody is suitable for immunoblotting at 1-2 μg/ml concentration. For capture ELISA, a final concentration of 2 μg/ml may be used.
Physical form
Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline
Preparation Note
Purified using protein G
Analysis Note
The antibody neutralizes the biological activity of recombinant human eotaxin-2. It exhibits less than 0.03% cross-reactivity with recombinant human eotaxin, MIP-1α, and MCP-3.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
1 of 1
Cet article | |||
|---|---|---|---|
| clone 61016.11, monoclonal | clone 5334, monoclonal | clone 24822, monoclonal | clone 3B1, monoclonal |
| species reactivity human | species reactivity human | species reactivity human | species reactivity human |
| biological source mouse | biological source mouse | biological source mouse | biological source mouse |
| conjugate unconjugated | conjugate unconjugated | conjugate unconjugated | conjugate unconjugated |
| Gene Information human ... CCL24(6369) | Gene Information human ... IL2(3558) | Gene Information human ... CCL2(6347) | Gene Information human ... MS4A2(2206) |
| antibody form purified immunoglobulin | antibody form purified immunoglobulin | antibody form purified immunoglobulin | antibody form purified immunoglobulin |
Still not finding the right product?
Essayez notre Outil de sélection de produits pour affiner vos choix.
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Contenu apparenté
Intracellular localization and release of eotaxin from normal eosinophils
Nakajima T et al
Febs Letters, 343, 226-230 (1998)
Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
Sallusto F et al
Science, 2777, 2005-2007 (1997)
The p38 MAP kinase and myosin light chain kinase (MLCK) critically regulate eosinophil chemotaxis in response to eotaxin
Alam R et al
The Journal of Allergy and Clinical Immunology, 103, S56-S56 (1999)
Numéro d'article de commerce international
| Référence | GTIN |
|---|---|
| E5768-500UG | 04061832714196 |